MM-141
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MM-141, covering 2016-08-04 to 2018-09-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer [Phase 2]